Chris Towers unveils affordable upside targets Fantasy managers shouldn't ignore ...

Nemetschek SE is rated a Buy with Q3/25 revenue up 15.8% y/y, EBIT up 33.9%, and free cash flow up 48.2%. Learn more about ...

During Nasdaq’s Investor Day presentation on February 25, 2026, the company will discuss several key long-term metrics that show the scale and breadth of its transformation into a leading technology ...

LONDON, Feb 25 () - Britain's Heathrow Airport said it expected to see 85 million passengers this ‌year, representing growth ...

The NFL is settling into offseason mode after the Seahawks were crowned Super Bowl champions earlier in February. The day ...

Myriad Genetics (MYGN) jumps on an earnings beat, raising 2026 revenue targets to $860M-$880M and highlighting oncology test growth.

Few pitchers on the planet have the ability Lagrange possesses when he uncorks a ball to home plate. Can he harness his command?

While sitting at 43-14, but vulnerable, is Oklahoma City Thunder's dynasty momentum slipping? Or, there's still hope? : blown 6 double-digit leads this season (more than all last year's title run).

Apple's expected less-expensive MacBook is one of the company's worst-kept secrets, but if it's priced right, it could become a huge hit — just as certain previous MacBooks did.

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's ...

What was once a dominant and high-traction primary market has turned into a far more subdued and cautious space, with investors discovering that listing gains are no longer a given.

This story has been updated with commentary from Community Health Systems' quarterly earnings call. | Amid commentary on ...